Charles Schwab
PGEN icon

Charles Schwab’s Precigen PGEN Stock Holding History

Charles Schwab’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.64M Buy
1,515,853
+55,233
+4% +$239K ﹤0.01% 2227
2026
Q1 		$5.65M Sell
1,460,620
-46,135
-3% -$189K ﹤0.01% 2353
2025
Q4 		$6.3M Buy
1,506,755
+246,842
+20% +$955K ﹤0.01% 2344
2025
Q3 		$4.15M Sell
1,259,913
-10,785
-0.8% -$30.4K ﹤0.01% 2518
2025
Q2 		$1.8M Buy
1,270,698
+53,934
+4% +$76.6K ﹤0.01% 2696
2025
Q1 		$1.81M Sell
1,216,764
-62,098
-5% -$97.8K ﹤0.01% 2647
2024
Q4 		$1.43M Buy
1,278,862
+56,012
+5% +$47.8K ﹤0.01% 2786
2024
Q3 		$1.16M Buy
1,222,850
+127,467
+12% +$161K ﹤0.01% 2875
2024
Q2 		$1.73M Buy
1,095,383
+26,856
+3% +$39K ﹤0.01% 2745
2024
Q1 		$1.55M Buy
1,068,527
+59,109
+6% +$84.9K ﹤0.01% 2667
2023
Q4 		$1.35M Sell
1,009,418
-51,102
-5% -$60K ﹤0.01% 2739
2023
Q3 		$1.51M Sell
1,060,520
-37,159
-3% -$52.7K ﹤0.01% 2674
2023
Q2 		$1.26M Buy
1,097,679
+63,081
+6% +$74.5K ﹤0.01% 2693
2023
Q1 		$1.1M Buy
1,034,598
+277,166
+37% +$400K ﹤0.01% 2705
2022
Q4 		$1.15M Buy
757,432
+10,907
+1% +$18.8K ﹤0.01% 2734
2022
Q3 		$1.58M Buy
746,525
+77,701
+12% +$164K ﹤0.01% 2649
2022
Q2 		$897K Sell
668,824
-54,314
-8% -$80.6K ﹤0.01% 2835
2022
Q1 		$1.53M Sell
723,138
-30,567
-4% -$74.4K ﹤0.01% 2731
2021
Q4 		$2.8M Buy
753,705
+15,361
+2% +$66.1K ﹤0.01% 2589
2021
Q3 		$3.69M Buy
738,344
+12,414
+2% +$71.5K ﹤0.01% 2515
2021
Q2 		$4.73M Buy
725,930
+142,587
+24% +$996K ﹤0.01% 2380
2021
Q1 		$4.02M Buy
583,343
+115,932
+25% +$980K ﹤0.01% 2395
2020
Q4 		$4.77M Buy
467,411
+14,537
+3% +$94.2K ﹤0.01% 2243
2020
Q3 		$1.59M Buy
452,874
+751
+0.2% +$3.56K ﹤0.01% 2572
2020
Q2 		$2.26M Buy
452,123
+4,941
+1% +$16.8K ﹤0.01% 2381
2020
Q1 		$1.52M Buy
447,182
+6,703
+2% +$28.9K ﹤0.01% 2378
2019
Q4 		$2.41M Buy
440,479
+11,781
+3% +$66.3K ﹤0.01% 2362
2019
Q3 		$2.45M Buy
428,698
+11,424
+3% +$77.6K ﹤0.01% 2325
2019
Q2 		$3.2M Buy
417,274
+5,612
+1% +$30.2K ﹤0.01% 2181
2019
Q1 		$2.17M Buy
411,662
+16,297
+4% +$113K ﹤0.01% 2343
2018
Q4 		$2.59M Sell
395,365
-332
-0.1% -$3.72K ﹤0.01% 2229
2018
Q3 		$6.81M Buy
395,697
+40,622
+11% +$604K ﹤0.01% 1868
2018
Q2 		$4.95M Buy
355,075
+143,993
+68% +$2.43M ﹤0.01% 2007
2018
Q1 		$3.24M Buy
211,082
+20,525
+11% +$293K ﹤0.01% 2144
2017
Q4 		$2.2M Sell
190,557
-7,591
-4% -$113K ﹤0.01% 2271
2017
Q3 		$3.77M Sell
198,148
-12,302
-6% -$253K ﹤0.01% 2028
2017
Q2 		$5.07M Sell
210,450
-16,531
-7% -$362K ﹤0.01% 1809
2017
Q1 		$4.5M Sell
226,981
-18,135
-7% -$405K ﹤0.01% 1818
2016
Q4 		$5.9M Buy
245,116
+39,979
+19% +$1.11M 0.01% 1628
2016
Q3 		$5.7M Buy
205,137
+46,028
+29% +$1.22M 0.01% 1557
2016
Q2 		$3.88M Sell
159,109
-7,934
-5% -$225K ﹤0.01% 1724
2016
Q1 		$5.61M Buy
167,043
+12,241
+8% +$385K 0.01% 1448
2015
Q4 		$4.63M Buy
154,802
+23,063
+18% +$777K 0.01% 1572
2015
Q3 		$4.15M Buy
131,739
+60,029
+84% +$2.93M 0.01% 1596
2015
Q2 		$3.47M Sell
71,710
-54,659
-43% -$2.3M ﹤0.01% 1787
2015
Q1 		$5.48M Buy
126,369
+24,243
+24% +$871K 0.01% 1449
2014
Q4 		$2.69M Buy
102,126
+12,355
+14% +$271K ﹤0.01% 1840
2014
Q3 		$1.59M Buy
89,771
+20,216
+29% +$413K ﹤0.01% 2087
2014
Q2 		$1.67M Buy
69,555
+37,607
+118% +$762K ﹤0.01% 2076
2014
Q1 		$803K Buy
31,948
+1,002
+3% +$27.7K ﹤0.01% 2390
2013
Q4 		$704K Buy
30,946
+5,516
+22% +$111K ﹤0.01% 2441
2013
Q3 		$590K Buy
+25,430
New +$587K ﹤0.01% 2481

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab's PGEN Position: Q2 2026 in Review

Charles Schwab increased its Precigen (PGEN) stake by 3.8% in Q2 2026, buying an estimated $239K and bringing the position to 1,515,853 shares worth $8.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2227.

Charles Schwab first reported a position in PGEN in Q3 2013 and has held it in 52 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Charles Schwab held 1,515,853 shares of Precigen worth $8.64M as of Q2 2026.
  • Charles Schwab bought 55,233 Precigen shares in Q2 2026, an estimated $239K.
  • Precigen made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2227 holding.
  • Charles Schwab first reported a position in Precigen in Q3 2013 and has held it in 52 quarters since.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.